Adaptimmune Therapeutics Plc (ADAP) — Defensive Interval Ratio
Adaptimmune Therapeutics Plc (ADAP) has a Defensive Interval Ratio of 205 days as of June 2025. Defensive assets of $28.89 Million (cash $-, short-term investments $0.00, receivables $28.89 Million) cover 205 days of daily cash needs of $141.13K/day. See Adaptimmune Therapeutics Plc (ADAP) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Adaptimmune Therapeutics Plc Defensive Interval Ratio (2011–2024)
This chart shows how Adaptimmune Therapeutics Plc's Defensive Interval Ratio has evolved across 14 annual periods from 2011 to 2024. As of June 2025, the ratio stands at 205 days, meaning defensive assets of $28.89 Million can fund 205 days of operations without new revenue. See debt-free asset ratio of Adaptimmune Therapeutics Plc to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Adaptimmune Therapeutics Plc (2011–2024)
The table below presents the year-by-year Defensive Interval Ratio for Adaptimmune Therapeutics Plc from 2011 to 2024, covering 14 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Adaptimmune Therapeutics Plc market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 432 days | $76.45 Million | $176.79K/day | $- | $60.47 Million | ▲ +182 days |
| 2023 | 250 days | $49.87 Million | $199.42K/day | $- | $2.95 Million | ▼ -512 days |
| 2022 | 762 days | $134.66 Million | $176.72K/day | $- | $96.57 Million | ▼ -718 days |
| 2021 | 1480 days | $253.64 Million | $171.35K/day | $- | $219.63 Million | ▼ -1622 days |
| 2020 | 3102 days | $332.06 Million | $107.05K/day | $- | $311.33 Million | ▲ +2481 days |
| 2019 | 621 days | $58.41 Million | $94.08K/day | $- | $39.13 Million | ▼ -1670 days |
| 2018 | 2291 days | $153.41 Million | $66.95K/day | $- | $136.75 Million | ▲ +1624 days |
| 2017 | 667 days | $135.88 Million | $203.60K/day | $- | $124.22 Million | ▲ +392 days |
| 2016 | 276 days | $30.42 Million | $110.33K/day | $- | $22.69 Million | ▼ -553 days |
| 2015 | 829 days | $60.74 Million | $73.31K/day | $- | $55.30 Million | ▲ +0 days |
| 2014 | 829 days | $60.74 Million | $73.31K/day | $- | $55.30 Million | ▲ +450 days |
| 2013 | 378 days | $55.00 Million | $145.50K/day | $- | $55.00 Million | ▲ +376 days |
| 2012 | 3 days | $27.37K | $10.87K/day | $- | $- | ▼ -58 days |
| 2011 | 61 days | $680.11K | $11.21K/day | $- | $- | — |